Wells Fargo
KRRO icon

Wells Fargo’s Korro Bio KRRO Stock Holding History

Wells Fargo’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$126K Buy
9,564
+6,975
+269% +$86.7K ﹤0.01% 5436
2026
Q1 		$29.3K Sell
2,589
-4,933
-66% -$54.3K ﹤0.01% 5641
2025
Q4 		$60.3K Buy
7,522
+2,352
+45% +$55K ﹤0.01% 5532
2025
Q3 		$248K Buy
5,170
+837
+19% +$18.6K ﹤0.01% 4811
2025
Q2 		$54.1K Buy
4,333
+540
+14% +$7.78K ﹤0.01% 5480
2025
Q1 		$66K Buy
3,793
+401
+12% +$11.9K ﹤0.01% 5297
2024
Q4 		$129K Buy
3,392
+831
+32% +$42.7K ﹤0.01% 5054
2024
Q3 		$85.6K Buy
2,561
+68
+3% +$2.86K ﹤0.01% 5109
2024
Q2 		$84.4K Buy
2,493
+2,444
+4,988% +$135K ﹤0.01% 5039
2024
Q1 		$4.41K Buy
49
+1
+2% +$55 ﹤0.01% 5913
2023
Q4 		$2.3K Buy
48
+36
+300% +$1.19K ﹤0.01% 6081
2023
Q3 		$228 Hold
12
– – ﹤0.01% 6554
2023
Q2 		$210 Hold
12
– – ﹤0.01% 6688
2023
Q1 		$299 Hold
12
– – ﹤0.01% 6666
2022
Q4 		$2.27K Hold
12
– – ﹤0.01% 5981
2022
Q3 		$1K Buy
12
+1
+9% +$102 ﹤0.01% 6377
2022
Q2 		$1K Sell
11
-65
-86% -$4.39K ﹤0.01% 6538
2022
Q1 		$8K Sell
76
-224
-75% -$42.8K ﹤0.01% 6344
2021
Q4 		$77K Buy
300
+293
+4,186% +$89.1K ﹤0.01% 5762
2021
Q3 		$2K Sell
7
-307
-98% -$121K ﹤0.01% 6577
2021
Q2 		$156K Sell
314
-136
-30% -$66.4K ﹤0.01% 5133
2021
Q1 		$213K Sell
450
-722
-62% -$1.4M ﹤0.01% 5126
2020
Q4 		$2.06M Buy
1,172
+78
+7% +$103K ﹤0.01% 3475
2020
Q3 		$1.05M Buy
1,094
+11
+1% +$11.8K ﹤0.01% 3820
2020
Q2 		$1.26M Buy
1,083
+984
+994% +$889K ﹤0.01% 3632
2020
Q1 		$88K Buy
99
+83
+519% +$89.6K ﹤0.01% 5126
2019
Q4 		$14K Buy
+16
New +$12.4K ﹤0.01% 5818

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Wells Fargo's KRRO Position: Q2 2026 in Review

Wells Fargo increased its Korro Bio (KRRO) stake by 269% in Q2 2026, buying an estimated $86.7K and bringing the position to 9,564 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #5436.

Wells Fargo first reported a position in KRRO in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.06M in Q4 2020. 106 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Wells Fargo held 9,564 shares of Korro Bio worth $126K as of Q2 2026.
  • Wells Fargo bought 6,975 Korro Bio shares in Q2 2026, an estimated $86.7K.
  • Korro Bio made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5436 holding.
  • Wells Fargo first reported a position in Korro Bio in Q4 2019 and has held it in 27 quarters since.
  • Wells Fargo's Korro Bio position peaked at $2.06M in Q4 2020.
  • 106 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.